Published Date：Dec. 2020
Industry：Pharma & Healthcare
Pages：81 Table Number：94
Single User Price：￥4860.00
Enterprise User Price：￥5800.00
Summary This study analysis was given on a worldwide scale, for instance, present and historical Biologic Drugs growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of Biologic Drugs production, Biologic Drugs revenue, Biologic Drugs consumption and Biologic Drugs price. According to the current situation, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. XYZResearch published a report for global Biologic Drugs market in this environment. In terms of revenue, this research report indicated that the global Biologic Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Biologic Drugs industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the production and revenue data in each of the sub-segments. The ?Roche aims at producing XX Biologic Drugs in 2020, with XX % production to take place in global market, ????Abbott Laboratories accounts for a volume share of XX %. At the upcoming analysis, this report discusses industrial policy, economic environment, in addition to the COVID-19 impact and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Biologic Drugs Market by XYZResearch Include NorthAmerica Asia Europe Middle East & Africa South America Competitive Analysis; Who are the Major Players in Biologic Drugs Market? Roche Abbott Laboratories Johnson & Johnson Merck & Co. Pfizer Amgen Sanofi Novartis Eli Lilly Amgen Major Type of Biologic Drugs Covered in XYZResearch report: Humira Remicade Rituxan Enbrel Lantus Avastin Herceptin Others Application Segments Covered in XYZResearch Market Diabetes Inflammation Auto-Immune Diseases Blood Diseases Cardiovascular Diseases Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Biologic Drugs Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Humira -Product Introduction and Major Manufacturers 1.1.2 Remicade -Product Introduction and Major Manufacturers 1.1.3 Rituxan -Product Introduction and Major Manufacturers 1.1.4 Enbrel -Product Introduction and Major Manufacturers 1.1.5 Lantus -Product Introduction and Major Manufacturers 1.1.6 Avastin -Product Introduction and Major Manufacturers 1.1.7 Herceptin -Product Introduction and Major Manufacturers 1.1.8 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Regional Market 2.1 Regional Market Share in Terms of Production (2019-2026) 2.2 Regional Market Share in Terms of Revenue (2019-2026) 2.3 Regional Market Share in Terms of Consumption (2019-2026) 3 Global Biologic Drugs Market Assessment by Type 3.1 Global Biologic Drugs Production by Type (2015-2026) 3.2 Global Biologic Drugs Revenue by Type (2015-2026) 3.3 North America Biologic Drugs Production and Revenue by Type (2015-2026) 3.4 Asia Biologic Drugs Production and Revenue by Type (2015-2026) 3.5 Europe Biologic Drugs Production and Revenue by Type (2015-2026) 3.6 Middle East & Africa Biologic Drugs Production and Revenue by Type (2015-2026) 3.7 South America Biologic Drugs Production and Revenue by Type (2015-2026) 4 Global Biologic Drugs Market Assessment by Application 4.1 Historical & Forecast Global Biologic Drugs Consumption, Different Application Field (2015-2026) 4.2 Historical & Forecast North America Biologic Drugs Consumption, Different Application Field (2015-2026) 4.3 Historical & Forecast Asia Biologic Drugs Consumption, Different Application Field (2015-2026) 4.4 Historical & Forecast Europe Biologic Drugs Consumption, Different Application Field (2015-2026) 4.5 Historical & Forecast Middle East & Africa Biologic Drugs Consumption, Different Application Field (2015-2026) 4.6 Historical & Forecast South America Biologic Drugs Consumption, Different Application Field (2015-2026) 5 North America 5.1 US Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 5.2 Canada Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 5.3 Mexico Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6 Asia 6.1 China Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6.2 Japan Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6.3 India Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6.4 Korea Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6.5 Southeat Asia Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7 Europe 7.1 Germany Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7.2 UK Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7.3 France Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7.4 Russia Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7.5 Italy Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8 Middle East and Africa 8.1 Saudi Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8.2 UAE Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8.3 Egypt Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8.4 Nigeria Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8.5 South Africa Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 9 South America 9.1 Brazil Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 9.2 Argentina Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 9.3 Colombia Biologic Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 10 Global Biologic Drugs Average Price Trend 10.1 Market Price for Each Type of Biologic Drugs in North America (2015-2026) 10.2 Market Price for Each Type of Biologic Drugs in Asia (2015-2026) 10.3 Market Price for Each Type of Biologic Drugs in Europe (2015-2026) 10.4 Market Price for Each Type of Biologic Drugs in Middle East & Africa (2015-2026) 10.5 Market Price for Each Type of Biologic Drugs in South America (2015-2026) 11 Value Chain (Impact of COVID-19) 11.1 Biologic Drugs Value Chain Analysis 11.1.1 Upstream 11.1.2 Downstream 11.2 COVID-19 Impact on Biologic Drugs Industry 11.2.1 Industrial Policy Issued Under the Epidemic Situation 11.3 Cost-Under the Epidemic Situation 11.3.1 Cost of Raw Material 11.4 Channel Analysis 11.4.1 Distribution Channel-Under the Epidemic Situation 11.4.2 Distributors 12 Biologic Drugs Competitive Analysis 12.1 Roche 12.1.1 Roche Company Profiles 12.1.2 Roche Product Introduction 12.1.3 Roche Biologic Drugs Production, Revenue (2015-2020) 12.1.4 SWOT Analysis 12.2 Abbott Laboratories 12.2.1 Abbott Laboratories Company Profiles 12.2.2 Abbott Laboratories Product Introduction 12.2.3 Abbott Laboratories Biologic Drugs Production, Revenue (2015-2020) 12.2.4 SWOT Analysis 12.3 Johnson & Johnson 12.3.1 Johnson & Johnson Company Profiles 12.3.2 Johnson & Johnson Product Introduction 12.3.3 Johnson & Johnson Biologic Drugs Production, Revenue (2015-2020) 12.3.4 SWOT Analysis 12.4 Merck & Co. 12.4.1 Merck & Co. Company Profiles 12.4.2 Merck & Co. Product Introduction 12.4.3 Merck & Co. Biologic Drugs Production, Revenue (2015-2020) 12.4.4 SWOT Analysis 12.5 Eli Lilly 12.5.1 Pfizer Company Profiles 12.5.2 Pfizer Product Introduction 12.5.3 Pfizer Biologic Drugs Production, Revenue (2015-2020) 12.5.4 SWOT Analysis 12.6 Amgen 12.6.1 Amgen Company Profiles 12.6.2 Amgen Product Introduction 12.6.3 Amgen Biologic Drugs Production, Revenue (2015-2020) 12.6.4 SWOT Analysis 12.7 Sanofi 12.7.1 Sanofi Company Profiles 12.7.2 Sanofi Product Introduction 12.7.3 Sanofi Biologic Drugs Production, Revenue (2015-2020) 12.7.4 SWOT Analysis 12.8 Novartis 12.8.1 Novartis Company Profiles 12.8.2 Novartis Product Introduction 12.8.3 Novartis Biologic Drugs Production, Revenue (2015-2020) 12.8.4 SWOT Analysis 12.9 Eli Lilly 12.9.1 Eli Lilly Company Profiles 12.9.2 Eli Lilly Product Introduction 12.9.3 Eli Lilly Biologic Drugs Production, Revenue (2015-2020) 12.9.4 SWOT Analysis 12.10 Amgen 12.10.1 Amgen Company Profiles 12.10.2 Amgen Product Introduction 12.10.3 Amgen Biologic Drugs Production, Revenue (2015-2020) 12.10.4 SWOT Analysis 13 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Biologic Drugs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table Regional Market Share in Terms of Production (2019-2026) Figure Regional Market Share in Terms of Production (2019 - 2020) Table Regional Market Share in Terms of Revenue (2019-2026) Figure Regional Market Share in Terms of Revenue (2019 - 2020) Figure Regional Market Share in Terms of Consumption (2019 - 2020) Figure Regional Market Share in Terms of Consumption (2019 - 2020) Table Global Biologic Drugs Production (K Unit) by Type (2015-2026) Figure Global Biologic Drugs Production (K Unit) and Growth Rate (2015-2026) Figure Global Biologic Drugs Production Market Share (%) by Type (2019 -2020) Table Global Biologic Drugs Revenue (Million USD) by Type (2015-2026) Figure Global Biologic Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure Global Biologic Drugs Revenue Market Share (%) by Type (2019-2020) Figure North America Biologic Drugs Production (K Unit) by Type (2015-2026) Figure North America Biologic Drugs Production (K Unit) and Growth Rate (2015-2026) Figure North America Biologic Drugs Revenue (Million USD) by Type (2015-2026) Figure North America Biologic Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure Asia Biologic Drugs Production (K Unit) by Type (2015-2026) Figure Asia Biologic Drugs Production (K Unit) and Growth Rate (2015-2026) Figure Asia Biologic Drugs Revenue (Million USD) by Type (2015-2026) Figure Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure Europe Biologic Drugs Production (K Unit) by Type (2015-2026) Figure Europe Biologic Drugs Production (K Unit) and Growth Rate (2015-2026) Figure Europe Biologic Drugs Revenue (Million USD) by Type (2015-2026) Figure Europe Biologic Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure Middle East & Africa Biologic Drugs Production (K Unit) by Type (2015-2026) Figure Middle East & Africa Biologic Drugs Production (K Unit) and Growth Rate (2015-2026) Figure Middle East & Africa Biologic Drugs Revenue (Million USD) by Type (2015-2026) Figure Middle East & Africa Biologic Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure South America Biologic Drugs Production (K Unit) by Type (2015-2026) Figure South America Biologic Drugs Production (K Unit) and Growth Rate (2015-2026) Figure South America Biologic Drugs Revenue (Million USD) by Type (2015-2026) Figure South America Biologic Drugs Revenue (Million USD) and Growth Rate (2015-2026) Table Historical & Forecast Biologic Drugs Different Application Field Consumption (K Unit) Figure Consumption (K Unit) and Growth Rate (2015-2026) Figure Different Application Field Consumption Market Share (%) (2019-2020) Table Historical & Forecast Biologic Drugs Different Application Field Consumption (K Unit) Figure North America Biologic Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure North America Biologic Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Biologic Drugs Different Application Field Consumption (K Unit) Figure Asia Biologic Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure Asia Biologic Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Biologic Drugs Different Application Field Consumption (K Unit) Figure Europe Biologic Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure Europe Biologic Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Biologic Drugs Different Application Field Consumption (K Unit) Figure Middle East & Africa Biologic Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure Middle East & Africa Biologic Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Biologic Drugs Different Application Field Consumption (K Unit) Figure South America Biologic Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure South America Biologic Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Biologic Drugs Different Application Field Consumption (K Unit) Table US Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Canada Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Mexico Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table China Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Japan Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table India Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Korea Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Southeast Asia Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Germany Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table UK Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table France Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Russia Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Italy Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Saudi Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table UAE Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Egypt Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Nigeria Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table South Africa Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Brazil Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Argentina Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Colombia Biologic Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Market Price (USD/Unit) for Each Type of Biologic Drugs in China Table Market Price (USD/Unit) for Each Type of Biologic Drugs in EU Table Market Price (USD/Unit) for Each Type of Biologic Drugs in USA Table Market Price (USD/Unit) for Each Type of Biologic Drugs in Japan Table Market Price (USD/Unit) for Each Type of Biologic Drugs in India Table Market Price (USD/Unit) for Each Type of Biologic Drugs in Southeast Asia Table Market Price (USD/Unit) for Each Type of Biologic Drugs in South America Figure Value Chain Structure of Biologic Drugs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Biologic Drugs Figure Cost Structure of Biologic Drugs in 2020 Table Distributors/Traders List Table ?Roche Profiles Table ?Roche Biologic Drugs Product Introduction Figure ?Roche Biologic Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ?Roche SWOT Analysis Table ????Abbott Laboratories Profiles Table ????Abbott Laboratories Biologic Drugs Product Introduction Figure ????Abbott Laboratories Biologic Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Abbott Laboratories SWOT Analysis Table ????Johnson & Johnson Profiles Table ????Johnson & Johnson Biologic Drugs Product Introduction Figure ????Johnson & Johnson Biologic Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Johnson & Johnson SWOT Analysis Table ????Merck & Co. Profiles Table ????Merck & Co. Biologic Drugs Product Introduction Figure ????Merck & Co. Biologic Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Merck & Co. SWOT Analysis Table ????Pfizer Profiles Table ????Pfizer Biologic Drugs Product Introduction Figure ????Pfizer Pharma & Healthcare Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Pfizer SWOT Analysis Table ????Amgen Profiles Table ????Amgen Biologic Drugs Product Introduction Figure ????Amgen Biologic Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Amgen SWOT Analysis Table ????Sanofi Profiles Table ????Sanofi Biologic Drugs Product Introduction Figure ????Sanofi Biologic Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Sanofi SWOT Analysis Table ????Novartis Profiles Table ????Novartis Biologic Drugs Product Introduction Figure ????Novartis Biologic Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Novartis SWOT Analysis Table ????Eli Lilly Profiles Table ????Eli Lilly Biologic Drugs Product Introduction Figure ????Eli Lilly Biologic Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Eli Lilly SWOT Analysis Table ????Amgen Profiles Table ????Amgen Biologic Drugs Product Introduction Figure ????Amgen Biologic Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
